EYPT - EyePoint Pharmaceuticals GAAP EPS of -$0.33 beats by $0.16 revenue of $14M beats by $5.3M
2024-03-07 07:04:05 ET
More on EyePoint Pharmaceuticals
- EyePoint Is Betting The Bank On EYP-1901
- EyePoint Pharmaceuticals: Innovating Eye Treatment, Yet A 'Hold' At This Time
- JP Morgan starts EyePoint at overweight, cites eye drug potential
- Seeking Alpha’s Quant Rating on EyePoint Pharmaceuticals
- Historical earnings data for EyePoint Pharmaceuticals